SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 109 filers reported holding SEELOS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $133,321 | -80.6% | 724,571 | +26.2% | 0.00% | -75.0% |
Q2 2023 | $685,913 | -4.7% | 573,986 | -17.9% | 0.01% | -20.0% |
Q3 2022 | $720,000 | -8.6% | 699,266 | -39.7% | 0.01% | -16.7% |
Q2 2022 | $788,000 | -66.5% | 1,158,956 | -58.7% | 0.01% | -68.4% |
Q1 2022 | $2,349,000 | -64.4% | 2,803,230 | -30.7% | 0.04% | -59.6% |
Q4 2021 | $6,597,000 | -37.5% | 4,047,231 | -7.6% | 0.09% | -45.3% |
Q3 2021 | $10,554,000 | +31.3% | 4,379,396 | +43.8% | 0.17% | +14.7% |
Q2 2021 | $8,037,000 | +126.5% | 3,044,432 | +328.0% | 0.15% | +89.9% |
Q1 2021 | $3,549,000 | – | 711,238 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,500,000 | $4,075,000 | 1.71% |
Connacht Asset Management LP | 498,925 | $813,000 | 0.79% |
GENDELL JEFFREY L | 2,449,267 | $3,992,000 | 0.32% |
MANGROVE PARTNERS IM, LLC | 2,133,436 | $3,478,000 | 0.21% |
Uniplan Investment Counsel, Inc. | 1,550,359 | $2,527,000 | 0.14% |
Financial Advocates Investment Management | 24,673 | $1,994,000 | 0.13% |
Connacht Asset Management LP | 72,300 | $118,000 | 0.12% |
Woodline Partners LP | 4,047,231 | $6,597,000 | 0.09% |
1492 Capital Management LLC | 108,286 | $177,000 | 0.09% |
Ikarian Capital, LLC | 244,171 | $398,000 | 0.06% |